By Tom Zanki ( June 17, 2015, 1:53 PM EDT) -- Irish drugmaker Allergan PLC said Tuesday it has agreed to buy facial aesthetics specialist Kythera Biopharmaceuticals Inc., which recently gained approval for an injection that reduces under-chin fat, for $2.1 billion in cash and stock, marking the Botox maker's latest acquisition across a rapidly consolidating pharmaceutical landscape....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.